mTOR: Role in cancer, metastasis and drug resistance

AK Murugan - Seminars in cancer biology, 2019 - Elsevier
Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that gets inputs from
the amino acids, nutrients, growth factor, and environmental cues to regulate varieties of …

Mechanisms of ATM activation

TT Paull - Annual review of biochemistry, 2015 - annualreviews.org
The ataxia-telangiectasia mutated (ATM) protein kinase is a master regulator of the DNA
damage response, and it coordinates checkpoint activation, DNA repair, and metabolic …

Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40

H Yang, X Jiang, B Li, HJ Yang, M Miller, A Yang… - Nature, 2017 - nature.com
The mechanistic target of rapamycin complex 1 (mTORC1) controls cell growth and
metabolism in response to nutrients, energy levels, and growth factors. It contains the …

mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases

M Palmieri, R Pal, HR Nelvagal, P Lotfi… - Nature …, 2017 - nature.com
Neurodegenerative diseases characterized by aberrant accumulation of undigested cellular
components represent unmet medical conditions for which the identification of actionable …

mTOR kinase structure, mechanism and regulation

H Yang, DG Rudge, JD Koos, B Vaidialingam, HJ Yang… - Nature, 2013 - nature.com
The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein
kinase, controls cell growth in response to nutrients and growth factors and is frequently …

Mitochondria are required for pro‐ageing features of the senescent phenotype

C Correia‐Melo, FDM Marques, R Anderson… - The EMBO …, 2016 - embopress.org
Cell senescence is an important tumour suppressor mechanism and driver of ageing. Both
functions are dependent on the development of the senescent phenotype, which involves an …

Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy

JS Lim, W Kim, HC Kang, SH Kim, AH Park, EK Park… - Nature medicine, 2015 - nature.com
Focal cortical dysplasia type II (FCDII) is a sporadic developmental malformation of the
cerebral cortex characterized by dysmorphic neurons, dyslamination and medically …

Target of rapamycin (TOR) in nutrient signaling and growth control

R Loewith, MN Hall - Genetics, 2011 - academic.oup.com
Abstract TOR (T arget O f R apamycin) is a highly conserved protein kinase that is important
in both fundamental and clinical biology. In fundamental biology, TOR is a nutrient-sensitive …

Glutaminolysis activates Rag-mTORC1 signaling

RV Durán, W Oppliger, AM Robitaille, L Heiserich… - Molecular cell, 2012 - cell.com
Amino acids control cell growth via activation of the highly conserved kinase TORC1.
Glutamine is a particularly important amino acid in cell growth control and metabolism …

A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

BC Grabiner, V Nardi, K Birsoy, R Possemato, K Shen… - Cancer discovery, 2014 - AACR
Genes encoding components of the PI3K–AKT–mTOR signaling axis are frequently mutated
in cancer, but few mutations have been characterized in MTOR, the gene encoding the …